Pathogenesis of Takayasu's arteritis: A 2011 update

Autoimmunity Reviews

Volumn 11, Issue 1, 2011, Pages 61-67

  Arnaud, Laurent ^a,b   Haroche, Julien ^a,b,c   Mathian, Alexis ^a,b,c   Gorochov, Guy ^b,c   Amoura, Zahir ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Immunology; Pathogenesis; Review; Takayasu arteritis; Vasculitis

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; PLATELET DERIVED GROWTH FACTOR; TOLL LIKE RECEPTOR; VASCULOTROPIN;

ADAPTIVE IMMUNITY; AORTA ARCH SYNDROME; B LYMPHOCYTE; CELL MIGRATION; CYTOTOXICITY; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; HUMAN; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; MONONUCLEAR CELL; NATURAL KILLER CELL; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; VASCULAR SMOOTH MUSCLE;

AORTA; HEAT-SHOCK PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; MUSCLE, SMOOTH, VASCULAR; TAKAYASU ARTERITIS;

EID: 80855130743     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.08.001     Document Type: Review

References (107)

1. Takayasu M. A case with unusual changes of the central vessels in the retina. Acta Soc Ophtalmol Jpn 1908, 12:554-555.
2. Numano F. The story of Takayasu arteritis. Rheumatology (Oxford) 2002, 41:103-106.
3. Arnaud L., Haroche J., Limal N., Toledano D., Gambotti L., Costedoat Chalumeau N., et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, north African, and black patients. Medicine (Baltimore) 2010, 89:1-17.
4. Lee G.Y., Jang S.Y., Ko S.M., Kim E.K., Lee S.H., Han H., et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol 2011 Feb 25, [Epub ahead of print].
5. Rav-Acha M., Plot L., Peled N., Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev 2007, 6:566-571.
6. Miller A., Basu N., Luqmani R. Assessment of systemic vasculitis. Autoimmun Rev 2008, 8:170-175.
7. Kallenberg C.G., Tadema H. Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "Autoimmunity and infection". Autoimmun Rev 2008, 8:29-32.
8. Noris M. Pathogenesis of Takayasu's arteritis. J Nephrol 2001, 14:506-513.
9. Lupi-Herrera E., Sanchez-Torres G., Marcushamer J., Mispireta J., Horwitz S., Vela J.E. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 1977, 93:94-103.
10. Seko Y., Minota S., Kawasaki A., Shinkai Y., Maeda K., Yagita H., et al. Perforin-secreting killer cell infiltration and expression of a 65-kd heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest 1994, 93:750-758.
11. Arnaud L., Haroche J., Malek Z., Archambaud F., Gambotti L., Grimon G., et al. Is (18)f-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?. Arthritis Rheum 2009, 60:1193-1200.
12. Vista E.G., Santos Estrella P.V., Lichauco J.J. Flourine-18 flourodeoxyglucose positron emission tomography as a non-invasive test of disease activity in Takayasu's arteritis - a report of four cases. Autoimmun Rev 2010, 9:503-506.
13. Chung J.W., Kim H.C., Choi Y.H., Kim S.J., Lee W., Park J.H. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 2007, 45:906-914.
14. Pryshchep O., Ma-Krupa W., Younge B.R., Goronzy J.J., Weyand C.M. Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation 2008, 118:1276-1284.
15. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 1988, 12:964-972.
16. Arnaud L., Haroche J., Toledano D., Cacoub P., Mathian A., Costedoat-Chalumeau N., et al. Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. Arthritis Rheum 2011, 63:1136-1140.
17. Barrat F.J., Coffman R.L. Development of tlr inhibitors for the treatment of autoimmune diseases. Immunol Rev 2008, 223:271-283.
18. Tse K., Horner A.A. Update on toll-like receptor-directed therapies for human disease. Ann Rheum Dis 2007, 66(Suppl. 3):iii77-iii80.
19. Deng J., Ma-Krupa W., Gewirtz A.T., Younge B.R., Goronzy J.J., Weyand C.M. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res 2009, 104:488-495.
20. Inder S.J., Bobryshev Y.V., Cherian S.M., Wang A.Y., Lord R.S., Masuda K., et al. Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: Involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions. Cardiovasc Surg 2000, 8:141-148.
21. Inder S.J., Bobryshev Y.V., Cherian S.M., Lord R.S., Masuda K., Yutani C. Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 2000, 51:565-579.
22. Krupa W.M., Dewan M., Jeon M.S., Kurtin P.J., Younge B.R., Goronzy J.J., et al. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol 2002, 161:1815-1823.
23. Ly K.H., Regent A., Tamby M.C., Mouthon L. Pathogenesis of giant cell arteritis: more than just an inflammatory condition?. Autoimmun Rev 2010, 9:635-645.
24. Lv N., Dang A., Wang Z., Zheng D., Liu G. Association of susceptibility to Takayasu arteritis in Chinese Han patients with hla-dpb1. Hum Immunol 2011 May 24, [Epub ahead of print].
25. Flores-Dominguez C., Hernandez-Pacheco G., Zuniga J., Gamboa R., Granados J., Reyes P.A., et al. Alleles of the major histocompatibility system associated with susceptibility to the development of Takayasu's arteritis. Gac Med Mex 2002, 138:177-183.
26. Vargas-Alarcon G., Hernandez-Pacheco G., Soto M.E., Murguia L.E., Perez-Hernandez N., Granados J., et al. Comparative study of the residues 63 and 67 on the hla-b molecule in patients with Takayasu's arteritis. Immunol Lett 2005, 96:225-229.
27. Yoshida M., Kimura A., Katsuragi K., Numano F., Sasazuki T. DNA typing of hla-b gene in Takayasu's arteritis. Tissue Antigens 1993, 42:87-90.
28. Bertipaglia B., Faggin E., Cillo U., Zanus G., Angelini A., Pauletto P. Is apoptosis of vascular smooth muscle cells involved in the development of Takayasu arteritis? Suggestions from a case report. Rheumatology (Oxford) Apr 2004, 44:484-487.
29. Seko Y., Sugishita K., Sato O., Takagi A., Tada Y., Matsuo H., et al. Expression of costimulatory molecules (4-1bbl and Fas) and major histocompatibility class I chain-related a (Mica) in aortic tissue with Takayasu's arteritis. J Vasc Res 2004, 41:84-90.
30. Vinay D.S., Kwon B.S. Role of 4-1bb in immune responses. Semin Immunol 1998, 10:481-489.
31. Wen T., Bukczynski J., Watts T.H. 4-1bb ligand-mediated costimulation of human t cells induces cd4 and cd8t cell expansion, cytokine production, and the development of cytolytic effector function. J Immunol 2002, 168:4897-4906.
32. Smyth M.J., Cretney E., Kelly J.M., Westwood J.A., Street S.E., Yagita H., et al. Activation of NK cell cytotoxicity. Mol Immunol 2005, 42:501-510.
33. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and t cells by nkg2d, a receptor for stress-inducible mica. Science 1999, 285:727-729.
34. Schultz D.R., Arnold P.I. Heat shock (stress) proteins and autoimmunity in rheumatic diseases. Semin Arthritis Rheum 1993, 22:357-374.
35. Mwipatayi B.P., Jeffery P.C., Beningfield S.J., Matley P.J., Naidoo N.G., Kalla A.A., et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 2005, 75:110-117.
36. Al-Aghbari K., Al-Motarreb A., Askar F. Takayasu's arteritis associated with tuberculosis in a young Yemeni woman. Heart Views 2011, 11:117-120.
37. Duzova A., Turkmen O., Cinar A., Cekirge S., Saatci U., Ozen S. Takayasu's arteritis and tuberculosis: a case report. Clin Rheumatol 2000, 19:486-489.
38. Serratrice J., Benyamine A., Vidal V., Talet H.B., Amri A.B., Ene N., et al. simultaneous occurrence of diffuse Takayasu's arteritis and severe disseminated tuberculosis. Rev Med Interne 2008, 29:520-523.
39. Soto M.E., Vargas-Alarcon G., Cicero-Sabido R., Ramirez E., Alvarez-Leon E., Reyes P.A. Comparison distribution of hla-b alleles in mexican patients with Takayasu arteritis and tuberculosis. Hum Immunol 2007, 68:449-453.
40. Aggarwal A., Chag M., Sinha N., Naik S. Takayasu's arteritis: role of mycobacterium tuberculosis and its 65kDa heat shock protein. Int J Cardiol 1996, 55:49-55.
41. Hernandez-Pando R., Reyes P., Espitia C., Wang Y., Rook G., Mancilla R. Raised agalactosyl IGG and antimycobacterial humoral immunity in Takayasu's arteritis. J Rheumatol 1994, 21:1870-1876.
42. Kumar Chauhan S., Kumar Tripathy N., Sinha N., Singh M., Nityanand S. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis. Clin Exp Immunol 2004, 138:547-553.
43. Moraes M.F., Ordway D., Oliveira L., Costa I.L., Badura R., Pinheiro M.N., et al. Cellular immune responses to mycobacterium tuberculosis in a patient with Takayasu's arteritis. Rev Port Cardiol 1999, 18:359-367.
44. Chauhan S.K., Singh M., Nityanand S. Reactivity of gamma/delta t cells to human 60-kd heat-shock protein and their cytotoxicity to aortic endothelial cells in Takayasu arteritis. Arthritis Rheum 2007, 56:2798-2802.
45. Karadag O., Aksu K., Sahin A., Zihni F.Y., Sener B., Inanc N., et al. Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and quantiferon-tb gold test. Rheumatol Int 2010, 30:1483-1487.
46. Arnaud L., Cambau E., Brocheriou I., Koskas F., Kieffer E., Piette J.C., et al. Absence of mycobacterium tuberculosis in arterial lesions from patients with Takayasu's arteritis. J Rheumatol 2009, 36:1682-1685.
47. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl 1992, 7:11-17.
48. Noguchi S., Numano F., Gravanis M.B., Wilcox J.N. Increased levels of soluble forms of adhesion molecules in Takayasu arteritis. Int J Cardiol 1998, 66(Suppl. 1):S23-S33. discussion S5-6.
49. de Souza A.W., Ataide Mariz H., Torres Reis Neto E., Diniz Arraes A.E., da Silva N.P., Sato E.I. Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients. Clin Rheumatol 2009, 28:379-383.
50. Yasukawa K., Terai M., Shulman S.T., Toyozaki T., Yajima S., Kohno Y., et al. Systemic production of vascular endothelial growth factor and FMS-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002, 105:766-769.
51. Brack A., Geisler A., Martinez-Taboada V.M., Younge B.R., Goronzy J.J., Weyand C.M. Giant cell vasculitis is a T cell-dependent disease. Mol Med 1997, 3:530-543.
52. Wagner A.D., Bjornsson J., Bartley G.B., Goronzy J.J., Weyand C.M. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol 1996, 148:1925-1933.
53. Sneller M.C. Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med 2002, 69(Suppl. 2):SII40-SII43.
54. Weyand C.M., Goronzy J.J. Medium- and large-vessel vasculitis. N Engl J Med 2003, 349:160-169.
55. Kaiser M., Younge B., Bjornsson J., Goronzy J.J., Weyand C.M. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999, 155:765-774.
56. Kaiser M., Weyand C.M., Bjornsson J., Goronzy J.J. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998, 41:623-633.
57. Sagar S., Ganguly N.K., Koicha M., Sharma B.K. Immunopathogenesis of Takayasu arteritis. Heart Vessels Suppl 1992, 7:85-90.
58. Nityanand S., Giscombe R., Srivastava S., Hjelmstrom P., Sanjeevi C.B., Sinha N., et al. A bias in the alphabeta t cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol 1997, 107:261-268.
59. Dhar J., Ganguly N.K., Kumari S., Sharma B.K. Role of calcium and protein kinase C in the activation of T cells in Takayasu's arteritis. Jpn Heart J 1995, 36:341-348.
60. Scott D.G., Salmon M., Scott D.L., Blann A., Bacon P.A., Walton K.W., et al. Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes?. Clin Rheumatol 1986, 5:517-522.
61. Seko Y., Sato O., Takagi A., Tada Y., Matsuo H., Yagita H., et al. Restricted usage of t-cell receptor valpha-vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation 1996, 93:1788-1790.
62. Seko Y., Takahashi N., Tada Y., Yagita H., Okumura K., Nagai R. Restricted usage of t-cell receptor vgamma-vdelta genes and expression of costimulatory molecules in Takayasu's arteritis. Int J Cardiol 2000, 75(Suppl. 1):S77-S83. discussion S5-7.
63. Weyand C.M., Schonberger J., Oppitz U., Hunder N.N., Hicok K.C., Goronzy J.J. Distinct vascular lesions in giant cell arteritis share identical t cell clonotypes. J Exp Med 1994, 179:951-960.
64. Deng J., Younge B.R., Olshen R.A., Goronzy J.J., Weyand C.M. Th17 and th1 t-cell responses in giant cell arteritis. Circulation 2010, 121:906-915.
65. Eid R.E., Rao D.A., Zhou J., Lo S.F., Ranjbaran H., Gallo A., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating t cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
66. Radtke F., Wilson A., Mancini S.J., MacDonald H.R. Notch regulation of lymphocyte development and function. Nat Immunol 2004, 5:247-253.
67. Piggott K., Deng J., Warrington K., Younge B., Kubo J.T., Desai M., et al. Blocking the notch pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation 2011, 123:309-318.
68. Maksimowicz-McKinnon K., Clark T.M., Hoffman G.S. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?. Medicine (Baltimore) 2009, 88:221-226.
69. Takebe N., Harris P.J., Warren R.Q., Ivy S.P. Targeting cancer stem cells by inhibiting WNT, NOTCH, and hedgehog pathways. Nat Rev Clin Oncol 2010, 8:97-106.
70. Teachey D.T., Seif A.E., Brown V.I., Bruno M., Bunte R.M., Chang Y.J., et al. Targeting notch signaling in autoimmune and lymphoproliferative disease. Blood 2008, 111:705-714.
71. Okada M., Kitahara M., Kishimoto S., Matsuda T., Hirano T., Kishimoto T. Il-6/bsf-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988, 141:1543-1549.
72. Luger T.A., Krutmann J., Kirnbauer R., Urbanski A., Schwarz T., Klappacher G., et al. Ifn-beta 2/il-6 augments the activity of human natural killer cells. J Immunol 1989, 143:1206-1209.
73. Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 1992, 5(Suppl. A):123-132.
74. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine rantes. Nature 1990, 347:669-671.
75. Noris M., Daina E., Gamba S., Bonazzola S., Remuzzi G. Interleukin-6 and rantes in Takayasu arteritis: a guide for therapeutic decisions?. Circulation 1999, 100:55-60.
76. Tripathy N.K., Sinha N., Nityanand S. Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity. Clin Exp Rheumatol 2004, 22:S27-S30.
77. Ma J., Luo X., Wu Q., Chen Z., Kou L., Wang H. Circulation levels of acute phase proteins in patients with Takayasu arteritis. J Vasc Surg 2010, 51:700-706.
78. Tripathy N.K., Chauhan S.K., Nityanand S. Cytokine mrna repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 2004, 138:369-374.
79. Matsuyama A., Sakai N., Ishigami M., Hiraoka H., Kashine S., Hirata A., et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 2003, 108:1469-1473.
80. Atzeni F., Doria A., Carrabba M., Turiel M., Sarzi-Puttini P. Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev 2007, 6:529-536.
81. Chan A.T., Flossmann O., Mukhtyar C., Jayne D.R., Luqmani R.A. The role of biologic therapies in the management of systemic vasculitis. Autoimmun Rev 2006, 5:273-278.
82. Hoffman G.S., Merkel P.A., Brasington R.D., Lenschow D.J., Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004, 50:2296-2304.
83. Molloy E.S., Langford C.A., Clark T.M., Gota C.E., Hoffman G.S. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008, 67:1567-1569.
84. Nishimoto N., Nakahara H., Yoshio-Hoshino N., Mima T. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum 2008, 58:1197-1200.
85. Gyotoku Y., Kakiuchi T., Nonaka Y., Saito Y., Ito I., Murao S. Immune complexes in Takayasu's arteritis. Clin Exp Immunol 1981, 45:246-252.
86. Eichhorn J., Sima D., Thiele B., Lindschau C., Turowski A., Schmidt H., et al. Anti-endothelial cell antibodies in Takayasu arteritis. Circulation 1996, 94:2396-2401.
87. Ito I. Aortitis syndrome with reference to the detection of antiaorta antibody from patients' sera. Jpn Circ J 1966, 30:75-79.
88. Ito I., Saito Y., Nonaka Y. Immunological aspects of aortitis syndrome. Jpn Circ J 1975, 39:459-462.
89. Nakao K., Ikeda M., Kimata S., Niitani H., Niyahara M. Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases. Circulation 1967, 35:1141-1155.
90. Ueda H., Ito I., Saito Y. Autoantibodies in cardiovascular disease. Jpn J Clin Med 1964, 22:1271-1278.
91. Wang H., Ma J., Wu Q., Luo X., Chen Z., Kou L. Circulating b lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis. J Vasc Surg 2010, 53:174-180.
92. Chopra P., Datta R.K., Dasgupta A., Bhargava S. Non specific aortoarteritis (Takayasu's disease). An immunologic and autopsy study. Jpn Heart J 1983, 24:549-556.
93. Dhingra R., Talwar K.K., Chopra P., Kumar R. An enzyme linked immunosorbent assay for detection of anti-aorta antibodies in Takayasu arteritis patients. Int J Cardiol 1993, 40:237-242.
94. Dhingra R., Chopra P., Talwar K.K., Kumar R. Enzyme-linked immunosorbent assay and immunoblot study in Takayasu's arteritis patients. Indian Heart J 1998, 50:428-432.
95. Baltazares M., Mendoza F., Dabague J., Reyes P.A. Antiaorta antibodies and Takayasu arteritis. Int J Cardiol 1998, 66(Suppl. 1):S183-S187. discussion S9.
96. Tripathy N.K., Upadhyaya S., Sinha N., Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 2001, 28:805-808.
97. Tobon G.J., Alard J.E., Youinou P., Jamin C. Are autoantibodies triggering endothelial cell apoptosis really pathogenic?. Autoimmun Rev 2009, 8:605-610.
98. Nishino Y., Tamai M., Kawakami A., Koga T., Makiyama J., Maeda Y., et al. Serum levels of Baff for assessing the disease activity of Takayasu arteritis. Clin Exp Rheumatol 2010, 28:14-17.
99. Jacobi A.M., Huang W., Wang T., Freimuth W., Sanz I., Furie R., et al. Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: extension of a phase ii, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum 2009, 62:201-210.
100. Misra R., Aggarwal A., Chag M., Sinha N., Shrivastava S. Raised anticardiolipin antibodies in Takayasu's arteritis. Lancet 1994, 343:1644-1645.
101. Yokoi K., Akaike M., Shigekiyo T., Saito S. an elderly patient with Takayasu's arteritis associated with antiphospholipid antibodies. Nippon Ronen Igakkai Zasshi 1994, 31:716-719.
102. Yokoi K., Hosoi E., Akaike M., Shigekiyo T., Saito S. Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases. Angiology 1996, 47:315-319.
103. Nava A., Senecal J.L., Banales J.L., Raymond I., Reyes P.A. Absence of antiphospholipid/co-factor antibodies in Takayasu arteritis. Int J Cardiol 2000, 75(Suppl. 1):S99-S104.
104. Nityanand S., Mishra K., Shrivastava S., Holm G., Lefvert A.K. Autoantibodies against cardiolipin and endothelial cells in Takayasu's arteritis: prevalence and isotype distribution. Br J Rheumatol 1997, 36:923-924.
105. Uppal S.S., Verma S. Analysis of the clinical profile, autoimmune phenomena and T cell subsets (cd4 and cd8) in Takayasu's arteritis: a hospital-based study. Clin Exp Rheumatol 2003, 21:S112-S116.
106. Tripathy N.K., Sinha N., Nityanand S. Anti-annexin v antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003, 134:360-364.
107. Liang P., Hoffman G.S. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005, 17:16-24.